The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Compounded medications aren't FDA-approved, but the facilities in ... drugmakers and the FDA share concerns about fake or subpar weight loss drugs — even though regulated compounders often ...

Leigh-Anne Lagden, 26, opened up about being hospitalized after accidentally overdosing on knockoff weight loss injections ...

It also said it would not take enforcement action — for now — against pharmacies making their own versions of weight-loss drugs based ... to the FDA-approved drug,” Scott Brunner, chief ...

These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... patients are aware that Novo Nordisk is the only company in the U.S. with FDA-approved medicines ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Feb. 22, 2024 When the semaglutide medication Wegovy first hit the market in 2021, it became the first weight-loss drug to ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...